CMMB insider trading — Chemomab Therapeutics Ltd.
Over the last 90 days, insiders at Chemomab Therapeutics Ltd. (CMMB) made 0 open-market purchases worth $0 and 2 open-market sales worth $7K, making them net sellers by $7K. The largest sale was by Cohen Neil Harris (Director), who sold 1,304 shares for $4K on Aug 27, 2026.
Updated Oct 16, 2026.
Recent CMMB insider transactions
Every Form 4 filed by Chemomab Therapeutics Ltd. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Cohen Neil Harris | Director | S · Sale | Direct | 1,000 | $2.80 | $3K | Form 4 |
| Aug 27, 2026 | Cohen Neil Harris | Director | S · Sale | Direct | 1,304 | $2.85 | $4K | Form 4 |
CMMB insider trading FAQ
Are insiders buying CMMB stock?
Not on the open market. In the last 90 days, Chemomab Therapeutics Ltd. insiders made no open-market purchases, and 2 open-market sales totaling $7K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading CMMB?
Recent sellers: Cohen Neil Harris.
Where does CMMB insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.